Both Established and Emerging companies face substantial business and technology transformation when introducing a new product to the market. For start-up pharmaceuticals, the transition from an R&D organization to a commercial revenue-generating company is a pivotal time that requires careful operational planning. This is to ensure limited resources are maximized not only for that first launch, but also to prepare the path for the company’s sustainability and subsequent success of the company’s pipeline. There are some elements that consistently rise to the top for every one of these launches and are part of the assessment a company would benefit from as it initiates this type of program.

Download Attachment

See all Member News